Hemispherx BioPharma (HEB)

[JohnnyD3]

This may or may not depend on finding a senior partner - but it looks like the NIH is willing to fund a clinical trial.

http://www.meaction.net/2015/12/21/nih-considering-ampligen-and-rituximab-trials/

Here is the NIH/CDC plan presented last week - in phase 3 of the plan, they already know they will be using an " immunomodulatory agent". That says ampligen to me, not rituximab.

http://www.cdc.gov/cdcgrandrounds/pdf/archives/2016/feb2016.pdf

Phase III
To conduct an early phase intervention study with an immunomodulatory agent that targets biomarkers validated in Phase II

Page 48 of the presentation